Literature DB >> 22531820

Renal efflux transporter expression in pregnant mice with Type I diabetes.

Lindsay L Yacovino1, Lauren M Aleksunes.   

Abstract

Prior research suggests that sex hormones and metabolic changes, such as obesity and hyperglycemia, can alter renal transporter expression in rodents. The purpose of this study was to characterize the expression of kidney efflux transporters and regulatory transcription factors in response to Type I diabetes and pregnancy. Female C57BL/6 mice were treated with multiple low doses of streptozotocin (STZ) to induce hyperglycemia and then mated with normoglycemic male mice. Transporter mRNA and protein expression were quantified in kidneys from vehicle- and STZ-treated non-pregnant and pregnant mice on gestation day 14. Pregnancy decreased the expression of Mdr1b, Mrp4, and 5 proteins and increased the mRNA and protein expression of Mrp3 by 50-60%. STZ treatment elevated Mrp1, 2, 4, and 5 and reduced Mrp3, 6, and Mdr1b mRNA and/or protein in non-pregnant mice. Pregnancy had little effect on STZ-mediated changes in renal efflux transporter expression. Transcriptional profiles of Hnf1α, PXR, AhR, and Nrf2 were altered in patterns similar to some efflux transporters suggesting potential involvement in their regulation. Taken together, these results suggest that renal drug efflux transporters and regulatory signaling pathways are altered by endocrine and metabolic changes that occur during pregnancy and Type I diabetes.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531820      PMCID: PMC3370395          DOI: 10.1016/j.toxlet.2012.04.008

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  28 in total

1.  Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha.

Authors:  J M Maher; A L Slitt; T N Callaghan; X Cheng; C Cheung; F J Gonzalez; C D Klaassen
Journal:  Biochem Pharmacol       Date:  2006-03-30       Impact factor: 5.858

2.  Type 1 diabetes mellitus and pregnancy.

Authors:  Roberto Vargas; John T Repke; Serdar H Ural
Journal:  Rev Obstet Gynecol       Date:  2010

Review 3.  Oxidative stress and diabetic kidney disease.

Authors:  Robert C Stanton
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

4.  Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.

Authors:  Lauren M Aleksunes; Michael J Goedken; Cheryl E Rockwell; Juergen Thomale; Jose E Manautou; Curtis D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  2010-07-06       Impact factor: 4.030

5.  Renal and hepatic transporter expression in type 2 diabetic rats.

Authors:  Michael T Nowicki; Lauren M Aleksunes; Sharmilee P Sawant; Ankur V Dnyanmote; Harihara M Mehendale; José E Manautou
Journal:  Drug Metab Lett       Date:  2008-01

6.  Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway.

Authors:  Jonathan M Maher; Matthew Z Dieter; Lauren M Aleksunes; Angela L Slitt; Grace Guo; Yuji Tanaka; George L Scheffer; Jefferson Y Chan; Jose E Manautou; Ying Chen; Timothy P Dalton; Masayuki Yamamoto; Curtis D Klaassen
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

7.  Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity.

Authors:  Qiuqiong Cheng; Lauren M Aleksunes; José E Manautou; Nathan J Cherrington; George L Scheffer; Hideki Yamasaki; Angela L Slitt
Journal:  Mol Pharm       Date:  2008-01-12       Impact factor: 4.939

8.  Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes.

Authors:  Xiaoqing He; Hong Kan; Lu Cai; Qiang Ma
Journal:  J Mol Cell Cardiol       Date:  2008-11-01       Impact factor: 5.000

9.  Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice.

Authors:  Vijay R More; Xia Wen; Paul E Thomas; Lauren M Aleksunes; Angela L Slitt
Journal:  Comp Hepatol       Date:  2012-04-23

10.  Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study.

Authors:  M F Hebert; T R Easterling; B Kirby; D B Carr; M L Buchanan; T Rutherford; K E Thummel; D P Fishbein; J D Unadkat
Journal:  Clin Pharmacol Ther       Date:  2008-02-20       Impact factor: 6.903

View more
  5 in total

Review 1.  Endocrine and metabolic regulation of renal drug transporters.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2012-08-29       Impact factor: 3.642

Review 2.  An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics.

Authors:  Ahizechukwu C Eke
Journal:  J Basic Clin Physiol Pharmacol       Date:  2021-12-08

Review 3.  Altered Expression of Transporters, its Potential Mechanisms and Influences in the Liver of Rodent Models Associated with Diabetes Mellitus and Obesity.

Authors:  Leilei Ma; Lei He; Le Wang; Li Li; Xuena Lin; Guoyu Pan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-06       Impact factor: 2.441

4.  Multidrug resistance-associated protein 4 (Mrp4) is a novel genetic factor in the pathogenesis of obesity and diabetes.

Authors:  Ajay C Donepudi; Yoojin Lee; Ji-Young Lee; John D Schuetz; José E Manautou
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.191

5.  Quantitative Proteomics Reveals Changes in Transporter Protein Abundance in Liver, Kidney and Brain of Mice by Pregnancy.

Authors:  Michael Z Liao; Chunying Gao; Deepak Kumar Bhatt; Bhagwat Prasad; Qingcheng Mao
Journal:  Drug Metab Lett       Date:  2018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.